Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 19, Issue 11, Pages -Publisher
MDPI
DOI: 10.3390/ijms19113621
Keywords
multiple myeloma; prevention; monoclonal gammopathy of undetermined significance; plasma cell disease; therapy
Funding
- American Cancer Society [IRG-15-176-40]
- NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Multiple myeloma is an invariably fatal cancer of plasma cells. Despite tremendous advances in treatment, this malignancy remains incurable in most individuals. We postulate that strategies aimed at prevention have the potential to be more effective in preventing myeloma-related death than additional pharmaceutical strategies aimed at treating advanced disease. Here, we present a rationale for the development of prevention therapy and highlight potential target areas of study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available